Randomized Clinical Trial of Miltefosine to Treat Mucosal Leishmaniasis at Federal District, Brazil

NCT01377974 Phase 2 COMPLETED

The purpose of this study is to determine whether miltefosine is effective in the treatment of mucosal leishmaniasis compared to meglumine antimoniate, the standard treatment.

Details

Lead sponsor	Brasilia University Hospital
Phase	Phase 2
Status	COMPLETED
Enrolment	40
Start date	2009-07
Completion	2014-12

Conditions

• Leishmaniasis
• Leishmaniasis, Mucocutaneous

Interventions

• Miltefosine
• Standard Treatment Meglumine antimoniate

Primary outcomes

• Cure — 6 months
  Re-epithelizations of mucosal ulcers or regression of symptoms

Countries

Brazil